Floatz logo

16.ALPHA.-FLUOROESTRADIOL

Breast Neoplasm

University of PennsylvaniaSmall moleculePhase 2Dormant
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
30/ 100
Competitive Position
81/ 100

Competitive context

177 Active assets in the Breast Neoplasm cohort.

Asset / SponsorPhaseRating
Inno-206
Merck Sharp & Dohme LLC
Phase 4BB
EXEMESTANE
Fujian Cancer Hospital
Phase 4BB
Cyclophosphamide
Merck Sharp & Dohme LLC
Phase 4BB
TAMOXIFEN
Eli Lilly and Company
Phase 3BB
Docetaxel
Universitas Airlangga
Phase 4BB

View all 50 →

Same molecule, other indications

16.ALPHA.-FLUOROESTRADIOL is also rated in:

breast cancerDormant
B
Indicative ·
56 / 100
View asset →
estrogen-receptor positive breast cancerDormant
CCC
Indicative ·
49 / 100
View asset →
ductal breast carcinoma in situDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →